Fondita European Micro Cap

The smallest companies albeit the biggest winners in Europe!

The fund

Fondita European Micro Cap is an equity fund that invests in a limited number of small European quality companies with a market capitalisation of up to EUR 800 million. The fund has a concentrated portfolio and invests in companies in the long term, where growth is primarily driven by structural drivers and societal changes.

Micro caps

There is stronger growth and greater potential in Europe’s smallest listed companies. Micro caps in Europe have usually had better growth than large companies over time, which normally results in a better share price development. These companies often have a niche focus, show good profitability, and enjoy a strong market position in their home market.

The fund’s driving forces are changes in the health and well-being of individuals and shifts in consumption behaviour. This also includes digitisation in society, an increased focus on the environment and climate, and the manufacturing industry’s progress towards increasingly automated processes.

The fund invests in micro-companies that have already succeeded in their home market and where we see good growth in the coming years. In the longer term, these companies have the possibility to succeed internationally. 

Sustainability
Read more about the fund’s sustainability principles:
Fund facts

31.10.2022

Fund size (M€)
35,3
ISIN (A)
FI4000242847
ISIN (B)
FI4000242854
Legal structure
UCITS
Currency
EUR
Management fee
2,00 % p.a.
Risk profile
6/7
SFDR Classification
Article 8
Top holdings
Marlowe (GB)
6,3 %
Pharmanutra (IT)
5,8 %
Nexus (DE)
5,1 %
Coltene Holding (CH)
4,3 %
PharmaSGP Holding (DE)
4,3 %
Germany
34 %
Great Britain
18 %
Sweden
14 %
Italy
10 %
Finland
6 %
Return
1 month
3,8 %
3 months
-13,4 %
6 months
-18,5 %
YTD
-35,0 %
1 year
-33,7 %
3 years
23,4 %
5 years
9,2 %
since launch (7.3.2017)
34,3 %
since launch p.a.
5,4 %
Sector division
Health Care
31 %
Industrials
29 %
Information Technology
20 %
Consumer Staples
7 %
Consumer Discretionary
5 %
Communication Services
2 %
Other
5 %
Top 10 holdings
Marlowe (GB)
6,3 %
Pharmanutra (IT)
5,8 %
Nexus (DE)
5,1 %
Coltene Holding (CH)
4,3 %
PharmaSGP Holding (DE)
4,3 %
Datagroup (DE)
4,2 %
ADDvise (SE)
3,9 %
Medios (DE)
3,6 %
Sdiptech (SE)
3,3 %
2G Energy (DE)
3,3 %
Country division
Germany
34 %
Great Britain
18 %
Sweden
14 %
Italy
10 %
Finland
6 %
Switzerland
6 %
Other
11 %
Currency exposure
EUR
58 %
GBP
18 %
SEK
14 %
CHF
6 %
DKK
2 %
NOK
1 %
Fees
TER
2,00 %
Subscription fee
0,00 %
Redemption fee
1,00 %

Total client relationship allow for changes in tariff rate.

Documents

FUND INFOMATION
KIID
Fund rules
Prospectus
REPORTS
Monthly report
Annual report
SUSTAINABILITY DOCUMENTS
Responsible Investment Policy
Exclusion list

This is marketing communication. The past performance of the investment fund does not provide any guarantee of future results. Read the fund prospectus and KIID before making any investment decisions. The fund prospectus and KIID are available on English, Finnish and Swedish at our website.

Latest news
Fondita Sustainable Europe meets the Nordic Swan Ecolabel’s new stricter sustainability requirements

Fondita Sustainable Europe obtained the Nordic Swan Ecolabel, which is the leading environmental label in the Nordics, as one of the first ... Read more

Fondita strengthens its engagment efforts by becoming an investor signatory to the CDP Climate, Water and Forest program

Fondita has signed up to the CDP Climate, Water and Forests Program. By taking part in the work of this global non-profit ... Read more

Web design: Wikström Media
Fondita online Fondita
online